6471 - 6480 of 9034 Results
Title
Year
- Fox Insight: a Large-Scale Web-Enabled Parkinson’s Disease Study (P4.007)2017RESTRICTEDTitle: Fox Insight: a Large-Scale Web-Enabled Parkinson’s Disease Study (P4.007)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 88Issue #: 16_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.88.16_supplement.p4.007Citation Count: 0
- Feasibility and Safety of Multisite Tissue and Biofluid Sampling for Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4) (P1.013)2017RESTRICTEDTitle: Feasibility and Safety of Multisite Tissue and Biofluid Sampling for Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4) (P1.013)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 88Issue #: 16_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.88.16_supplement.p1.013Citation Count: 0
-
OPENTitle: Abstract #81: Improving Neurostimulation Clinical Trial Design with Patient Experience DataJournal Name: Brain StimulationPublisher: Elsevier BVVol: 12Issue #: 2Start Page: e28End Page: e29Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brs.2018.12.088Best OA location URL: https://doaj.org/article/33431349c85d454db7ad2af33222a015Citation Count: 0
- Announcing a New Continuing Medical Education Course2013RESTRICTEDTitle: Announcing a New Continuing Medical Education CourseJournal Name: Cognitive and Behavioral NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 26Issue #: 2Start Page: 56End Page: 58Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wnn.0b013e31829af2fbCitation Count: 1
- P4‐308: CSF α‐synuclein, BETA‐AMYLOID 1–42 and tau proteins: Relationship to clinical parameters in early Parkinson's disease2012RESTRICTEDTitle: P4‐308: CSF α‐synuclein, BETA‐AMYLOID 1–42 and tau proteins: Relationship to clinical parameters in early Parkinson's diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 8Issue #: 4S_Part_21Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2013.08.089Citation Count: 0
- Pimavanserin for Psychotic Symptoms in People With Parkinsonism: A Second Chart Review2018RESTRICTEDTitle: Pimavanserin for Psychotic Symptoms in People With Parkinsonism: A Second Chart ReviewJournal Name: Clinical NeuropharmacologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 41Issue #: 5Start Page: 156End Page: 159Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wnf.0000000000000296Citation Count: 12
- Qualitative Imaging of Adeno-Associated Virus Serotype 2–Human Aromatic L-Amino Acid Decarboxylase Gene Therapy in a Phase I Study for the Treatment of Parkinson Disease2010RESTRICTEDTitle: Qualitative Imaging of Adeno-Associated Virus Serotype 2–Human Aromatic L-Amino Acid Decarboxylase Gene Therapy in a Phase I Study for the Treatment of Parkinson DiseaseJournal Name: NeurosurgeryPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 67Issue #: 5Start Page: 1377End Page: 1385Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1227/neu.0b013e3181f53a5cCitation Count: 71
-
OPENTitle: Beliefs About Use of Complementary Health Approaches for Parkinson's DiseaseJournal Name: Holistic Nursing PracticePublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 31Issue #: 5Start Page: 290End Page: 294Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/hnp.0000000000000229Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5664950Citation Count: 0
-
OPENTitle: Paraquat Neurotoxicity is Distinct from that of MPTP and RotenoneJournal Name: Toxicological SciencesPublisher: Oxford University Press (OUP)Vol: 88Issue #: 1Start Page: 193End Page: 201Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/toxsci/kfi304Best OA location URL: https://academic.oup.com/toxsci/article-pdf/88/1/193/4676394/kfi304.pdfCitation Count: 269
-
OPENTitle: Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injuryJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 10Issue #: 1SStart Page: S62End Page: 75Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jalz.2013.12.011Best OA location URL: http://doi.org/10.1016/j.jalz.2013.12.011Citation Count: 70